Naftifine
Overview
Naftifine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL626).
API suppliers (4)
Suppliers of Naftifine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- ERREGIERRE SPAItaly1 active DMF GMP on record
- SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Naftifine expires 31 Jan 2033. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine
- Canonical SMILES
- CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32
- InChIKey
- OZGNYLLQHRPOBR-DHZHZOJOSA-N
Do you supply Naftifine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.